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Abstract
Background: Colonisation with Panton-Valentine Leukocidin expressing strains of Staphylococcus aureus (PVL + SA)
is characterised by recurrent skin and soft tissue infections. While periorbital and orbital infections are common in
children and frequently caused by S. aureus the role of PVL + SA in recurrent eye infections has not been studied.
This study aimed to detect and report frequency and recurrence of periorbital or orbital infections as additional
symptoms of PVL + SA colonisation in children.
Methods: We conducted a retrospective cohort study of pediatric patients who were treated for PVL + SA skin
and soft tissue infection in our in- and outpatient clinics in Berlin, Germany from January 2012 to January 2017.
We identified cases with periorbital or orbital infections in the year prior to the first PVL + SA evidence. In these
cases, we conducted follow-up interviews by phone to determine recurrence of symptoms after the completion
of decolonisation procedures.
Results: Fifty pediatric patients (age range: one week to 17 years) were evaluated and treated for PVL + SA
infections in the reported time period. 19 patients (38%) reported periorbital infection or conjunctivitis, with recurrent
hordeola as the most frequent finding (n = 9; 18%). Reappearance of hordeola (n = 5) was associated with recurrence
of skin and soft tissue infections and/or de novo detection of PVL + SA. No further hordeola or other eye infections
occurred after successful decolonisation.
Conclusion: Our findings suggest a frequent involvement of periorbital skin in children with PVL + SA infections.
Pediatric patients with recurrent periorbital infections might benefit from PVL + SA screening and consecutive
decolonisation procedures.
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Background
Periorbital and orbital infections such as hordeola, con-
junctivitis, preseptal and orbital cellulitis are common
infections of the eye frequently caused by Staphylococcus
aureus (S. aureus) [1]. These infections are often the
result of ascending infections from the nasopharynx,
lacrimal sac or sinuses, common sites of S. aureus colon-
isation [2–4]. A hordeolum is an acute infection of the
glands of the eyelid. Hordeola are common, however,
there is no exact data on the incidence in children or
adults. Due to cosmetic reasons, pain, itching and swell-
ing recurrent hordeola can have a negative impact on a
child’s well-being. A recent Cochrane analysis demon-
strated a lack of standardised therapeutic guidelines for
single or recurrent hordeola [5].
S. aureus is the predominant cause for skin and soft tis-
sue infections (SSTI) in the world [6]. About 30% of the
general population carry the facultative pathogenic com-
mensal on their skin, mucosa and conjunctiva [7–9]. It is
primarily associated with non-invasive infections such as
skin abscesses, furunculosis and wound infections, less
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frequently with more severe infections such as sepsis,
osteomyelitis and pneumonia [10]. Nasal colonisation with
S. aureus has been described as an important risk factor in
developing SSTI and eye infections [2, 11–13].
Since the 1990s there has been an increase of infec-
tions with S. aureus strains expressing the exotoxin
Panton-Valentine Leukocidin (PVL + SA), which are
mainly characterised by recurrent SSTI [14].
Both methicillin-sensitive (MSSA) as well as methicillin-
resistant (MRSA) strains of S. aureus express the leukoci-
din encoded by bacteriophage genes lukS and lukF [15]. In
the US, most cases reported are caused by community
acquired methicillin resistant strains (CA-MRSA). Al-
though a rise of PVL + CA-MRSA has been reported, PVL
expression is still mainly associated with MSSA in Europe
[16–19].
In our routine clinical care a remarkable number of
children treated for PVL + SA SSTI reported multiple,
recurrent and bothersome hordeola. To our knowledge,
no studies on pediatric patients with PVL + SA skin in-
fection explored the involvement of the periorbital skin
or orbita. To date, there are several case reports on se-
vere eye infections with PVL + CA-MRSA, but none
with PVL +MSSA [20–22]. Reports on PVL + SA in
non-threatening periorbital infections are scarce.
This study aimed to detect and report frequency and
recurrence of periorbital or orbital infections as add-
itional symptoms of PVL + SA colonisation in children.
Methods
We conducted a retrospective cohort study of pediatric
patients who were treated for PVL + SA SSTI in our
pediatric in- and outpatient clinics from January 2012
to January 2017. At first presentation in our outpatient
clinic, parents of affected children underwent standard-
ized interviews comprising questions on localization
and frequency of SSTI and the occurrence and fre-
quency of hordeola up to one year prior to first evi-
dence of PVL + SA infections in the affected child.
Screening swabs from anterior nares and oropharynx
were taken in each patient. Patients who had been
tested positive for PVL + SA in at least one sample
(naso-pharyngeal screening swabs and/or swabs from
other location, e.g. material from SSTI) were included
in this study. In patients with periorbital infection at
presentation conjunctival swabs were taken. S. aureus
was detected by standard bacterial culture. Antimicro-
bial susceptibilities were determined using a Vitek® 2
automated system and the standard criteria of the
European Committee on Antimicrobial Susceptibility
Testing (EUCAST). The presence of the genes encod-
ing PVL (lukS and lukF) was assessed by polymerase
chain reaction (PCR) as described previously [23]. We
excluded patients who had been treated for PVL + SA
based on clinical data (typical symptoms plus PVL + SA
evidence in household members) but had been tested
negative for PVL + SA in the screening swabs.
Data were collected from electronic medical records
and archived files. Our main research parameter was the
occurrence of an eye infection within 12 months prior to
the first PVL + SA detection. We defined eye infection as
self-report or diagnosis of at least one periorbital or or-
bital infection. We defined recurrent infection as more
than two episodes during the reported time period. All
patients received decolonisation measures (consisting of:
topical application of mupirocin nasal ointment and
antiseptic treatment of mouth, hair, skin and housing
space for at least five days). Successful decolonisation
was defined as two negative screening swabs plus no re-
currence of SSTI. In patients with a history of eye infec-
tion we conducted follow up interviews by phone at
least two months after completion of decolonisation
measures to detect any recurrence of symptoms after
two months. Data were processed using Microsoft®
Excel® 2013.
Results
From January 2012 to January 2017 72 children had re-
ceived treatment for PVL + SA associated SSTI in our
clinic. 22 of these children were treated based on clinical
data alone and thus excluded from our study. The
remaining 50 patients were included. Median age was
6 years (Range: one week - 17 years). 54% of patients
were male (n = 27) and 46% female (n = 23). Seven chil-
dren (14%) were infected with PVL +MRSA, all others
(86%) with PVL +MSSA. In one patient (age: 17) with
multiple hordeola at presentation, PVL + SA was cul-
tured from conjunctival swabs. 19 patients (38%) re-
ported periorbital infections. The characteristics of these
patients are summarised in Table 1. Patients suffered
from eyelid abscesses (n = 5), preseptal cellulitis (n = 1),
conjunctivitis (n = 3) and hordeola (n = 12). Nine of
these patients (18%) reported recurrent hordeola, with
the onset of hordeola with a temporal connection to the
onset of SSTI (Fig. 1). Four patients were lost to
follow-up. In five patients eye infection reappeared, how-
ever, this was associated with recurrence of SSTI in all
five cases, with de novo detection of PVL + SA in two
cases. In the remaining ten patients no further hordeola
or periorbital infections occurred after successful decol-
onisation (follow-up: 10 weeks to 36 months).
Discussion
Our study demonstrates a high frequency of periorbital
infections in pediatric patients with PVL + SA associated
SSTI. Recurrent hordeola were observed in 18% of chil-
dren with PVL + SA colonisation. Other manifestations
comprised conjunctivitis, preseptal cellulitis and eyelid
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abscesses. In cases with successful and sustained decol-
onisation of PVL + SA no further episode of an eye in-
fection occurred.
A recent study of periorbital and orbital cellulitis from
the USA (n = 85, children) by Foster et al. [24] found PVL
+ SA evidence in 85% (n = 72) cases. In another study
(n = 49, patients of all ages) by Blomquist et al. [25] the
most common eye manifestations of CA-MRSA infection
were preseptal cellulitis/lid abscesses and conjunctivitis.
Hordeola were not evaluated in this study. A case series
(n = 9, adult patients) from the USA by Rutar et al. [26]
showed the capacity of PVL +MRSA to cause severe eye
Table 1 Characteristics of PVL positive children with eye infections
Patient Age at
diagnosis








No. months (years) yes/no n n n n yes/no yes/no yes/no/not
tested
1 114 (9) no > 2 0 0 0 no no not tested
2 1 (0) no 0 2 1 0 no no not tested
3 155 (12) no > 2 0 0 0 no no not tested
4 117 (9) no > 2 0 0 0 yes yes not tested
5 16 (1) no 1 0 0 0 yes yes yes
6 14 (1) no 0 1 1 0 no no not tested
7 205 (17) no > 2 0 0 0 yes yes yes
8 195 (16) no 1 0 0 1 Lost to follow-up Lost to follow-up not tested
9 80 (6) no 1 0 0 0 yes yes not tested
10 0 (0) yes 0 2 0 0 Lost to follow-up Lost to follow-up not tested
11 30 (2) no 0 0 0 1 no no not tested
12 199 (16) no > 2 0 0 0 no no not tested
13 54 (4) no > 2 0 0 0 no no not tested
14 9 (0) no 0 1 0 0 no no not tested
15 96 (8) no > 2 0 0 0 no no not tested
16 54 (4) no > 2 0 0 0 no no not tested
17 122 (10) no > 2 0 0 1 yes yes not tested
18 73 (6) yes 0 0 0 1 Lost to follow-up Lost to follow-up not tested
19 122 (10) yes 0 0 0 1 Lost to follow-up Lost to follow-up not tested
Fig. 1 Presentation of eye infection in PVL positive children. Circle: Proportion of PVL+ children (n = 50) with or without periorbital infection (POI).
Bar: Proportion of types of POI reported by the POI cohort
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infections. Nadig et al. [27] detected a high number
(n = 22 of 33) of PVL +MRSA in a study on eye infec-
tions in patients of all ages in India. Two case reports
from the UK by Alaghband et al. [22] and from the
USA by Rutar et al. [26] presented patients with severe
orbital infections resulting in blindness or bacteraemia
in otherwise healthy adults. Tsironi et al. [21] reported
the case of a previously healthy neonate who developed
orbital cellulitis with PVL +MRSA. Sueke et al. [28] re-
ported 9.5% PVL+SA in S. aureus isolates from bacter-
ial keratitis in the United Kingdom.
Our data suggests that not only pediatric patients with
severe but also those with recurrent but non-threatening
periorbital infections (especially hordeola) should be
tested for nasopharyngeal PVL + SA colonisation. In case
of PVL + SA detection decolonisation measures should
be recommended as described by Gillet et al. [29].
PVL detection depends on accurate sampling, culture
and PCR conditions [30]. This should be taken into
consideration in patients with typical symptoms but no
evidence of PVL + SA.
Also, routine testing for nasopharyngeal or conjunctival
colonisation with PVL + SA in patients with a history of
SSTI or eye infections may be limited by significant costs
of lukS/lukF PCR, especially for primary care physicians
with limited budgets.
Therefore, decolonization measures can occasionally
be considered in patients with a classic history of recur-
rent SSTI when testing for PVL + SA is not feasible or
negative.
For our study, we evaluated children who presented
with SSTI and were than assessed for a history of prior
eye infections. Because of this selection bias we do not
know the extent of PVL + SA colonisation in children
with eye infections but no history of SSTI. Further study
of children with recurrent eye infections could deter-
mine the frequency of PVL + SA. As a further limitation
of our study, we did not include routine screening of
conjunctival swabs, lid abscess material or hordeolum
tissue for PVL + SA. Further studies with microbiologic
testing of conjunctival swabs from symptomatic patients
or tissue obtained from hordeola are required to prove
the causal relationship between PVL + SA and recurrent
eye infections, especially hordeola.
Conclusion
Our findings suggest a frequent involvement of periorbital
skin in children with PVL + SA infections. Pediatric pa-
tients with recurrent periorbital infections might benefit
from PVL + SA screening and staphylococcal decolonisa-
tion procedures.
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